Global health sector strategies guide the health sector in implementing strategically focused responses to achieve the goals of ending AIDS, viral hepatitis B and C and sexually transmitted infections by 2030.
Department for HIV, Tuberculosis, Hepatitis and Sexually Transmitted Infections
The WHO Department leads the global effort to end the epidemics of HIV, tuberculosis (TB), hepatitis, and sexually transmitted infections (STIs), ensuring that every person has equitable access to highest-quality people-centred scientific evidence and services, regardless of who they are or where they live.
Featured
Ending TB is not just a public health problem, but a development challenge and opportunity. WHO’s post-2015 End TB Strategy, adopted by the World Health Assembly in 2014, aims to end the global TB epidemic as part of the newly adopted Sustainable Development Goals.
/global-hiv-hepatitis-and-stis-programmes-(hhs)/accountability-ghss-design-arrows.png?sfvrsn=284936b7_4 "accountability-ghss-design-arrows")
At-a-glance accountability dashboard for progress on global strategies for HIV, hepatitis and STIs with status on impact indicators, services delivered, and adoption of WHO policies. Country scorecards measure progress towards HIV incidence and mortality, and reaching service targets.
Publications
All →
27 July 2026
Global health sector strategies on HIV, viral hepatitis and sexually transmitted infections, 2022–2030:...
This report is the second in a series of biennial progress reports on the implementation of the Global health sector strategies on, respectively, HIV,...
27 July 2026
Consolidated guidance for strengthening national routine surveillance systems: updated HIV case definitions,...
WHO’s new consolidated guidance define the core components of a strong routine HIV surveillance system. Bringing together updated HIV and advanced...
22 July 2026
Consolidated HIV guidelines: service delivery
HIV remains a major public health challenge, especially in low- and middle-income countries. Inconsistent or delayed implementation of evidence-based...
14 July 2026
Guideline on doxycycline post-exposure prophylaxis for sexually transmitted infections among men who...
This guideline provides evidence-informed recommendations on the use of doxycycline post-exposure prophylaxis (PEP) for the prevention of bacterial sexually...
8 July 2026
WHO optimal antiretroviral dosing guidance: recommendations for dosing medicines for HIV prevention and...
This guidance presents updated recommendations on antiretroviral drug dosing for neonates, infants and children, drawing on recent pharmacokinetic evidence,...
28 April 2026
Global hepatitis report 2026
The Global hepatitis report 2026 provides the most comprehensive and up-to-date assessment of the global burden of hepatitis B (HBV) and hepatitis C (HCV),...
15 February 2026
Consolidated guidance on hepatitis B and C prevention, testing, treatment, service delivery and monitoring:...
This document consolidates, for the first time, WHO recommendations on the prevention, testing, treatment and monitoring of hepatitis B and C, and...
WHO's Department for HIV, Tuberculosis, Hepatitis and Sexually Transmitted Infections (STIs) has consolidated all existing normative guidance on STIs...
/global-hiv-hepatitis-and-stis-programmes-(hhs)/nbt-toolkit-banner.png?sfvrsn=e613817f_3 "nbt-toolkit-banner")
/global-hiv-hepatitis-and-stis-programmes-(hhs)/hivst-zimbabwe-afro-nologo-1920.jpg?sfvrsn=a70f3d5b_2 "hivst-zimbabwe-afro-nologo-1920")
/global-hiv-hepatitis-and-stis-programmes-(hhs)/community-testing-in-can-tho-viet-nam.jpg?sfvrsn=6de039d3_5 "community testing in Can Tho Viet Nam")
/global-hiv-hepatitis-and-stis-programmes-(hhs)/gustavo-distributes-an-hiv-and-other-stis-prevention-kit-in--brazil.jpg?sfvrsn=9222c363_9 "Gustavo distributes an HIV and other STIs prevention kit in Brazil")
